Download presentation
Presentation is loading. Please wait.
Published byTrevor French Modified over 8 years ago
1
Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib Ling Li, Lisheng Wang, Liang Li, Zhiqiang Wang, Yinwei Ho, Tinisha McDonald, Tessa L. Holyoake, WenYong Chen, Ravi Bhatia Cancer Cell Volume 21, Issue 2, Pages 266-281 (February 2012) DOI: 10.1016/j.ccr.2011.12.020 Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
2
Figure 1 Cancer Cell 2012 21, 266-281DOI: (10.1016/j.ccr.2011.12.020) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
3
Figure 2 Cancer Cell 2012 21, 266-281DOI: (10.1016/j.ccr.2011.12.020) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
4
Figure 3 Cancer Cell 2012 21, 266-281DOI: (10.1016/j.ccr.2011.12.020) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
5
Figure 4 Cancer Cell 2012 21, 266-281DOI: (10.1016/j.ccr.2011.12.020) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
6
Figure 5 Cancer Cell 2012 21, 266-281DOI: (10.1016/j.ccr.2011.12.020) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
7
Figure 6 Cancer Cell 2012 21, 266-281DOI: (10.1016/j.ccr.2011.12.020) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
8
Figure 7 Cancer Cell 2012 21, 266-281DOI: (10.1016/j.ccr.2011.12.020) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
9
Figure 8 Cancer Cell 2012 21, 266-281DOI: (10.1016/j.ccr.2011.12.020) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
10
Cancer Cell 2012 21, 266-281DOI: (10.1016/j.ccr.2011.12.020) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.